Pharmaceutically acceptable salt of trans4-[[(5s)-5-[[[3,5- is(trifluoromethyl)phenyl] methyl] (2-methyl-2h-tetrazol-5- yl)amino]2,3,4,5-tetrahydro-7,9-dimethyl-1h-1benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
PK201100669A0Undetermined Publication Date: 2011-09-24ELI LILLY & CO
0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- ELI LILLY & CO
- Filing Date
- 2011-09-14
- Publication Date
- 2011-09-24
Need to check novelty before this filing date? Find Prior Art
No text content released.